Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib. Commentary

Saved in:
Bibliographic Details
Published inBlood Vol. 109; no. 8
Main Authors ROSENWALD, Andreas, MULLIGAN, George, RICHARDSON, Paul, TREPICCHIO, William L, BROYL, Annemiek, SONNEVELD, Pieter, SHAUGHNESSY, John D, LEIF BERGSAGEL, P, SCHENKEIN, David, ESSELTINE, Dixie-Lee, BORAL, Anthony, ANDERSON, Kenneth C, MITSIADES, Constantine, BRYANT, Barb, FENGHUANG ZHAN, CHNG, Wee J, ROELS, Steven, KOENIG, Erik, FERGUS, Andrew, YONGSHENG HUANG
Format Journal Article
LanguageEnglish
Published Washington, DC The Americain Society of Hematology 2007
Subjects
Biological and medical sciences
Hematologic and hematopoietic diseases
Medical sciences
Antineoplastic agent
Bortezomib
Prognosis
Hematology
Analog
Proteasome inhibitor
Dipeptides
Clinical trial
Gene expression profile
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020